Combining Semaglutide With Exercise Preserves Muscle, Boosts Fat Loss

Resistance training may help preserve lean mass during GLP-1 therapy, according to new research.

New Research Tackles the Top GLP-1 Concern

One of the biggest concerns for anyone starting a GLP-1 medication like semaglutide is the fear of losing precious lean muscle mass along with fat. Fortunately, new research presented at the 2026 European Atherosclerosis Society (EAS) Congress offers a highly effective solution. The data shows that combining your medication with a structured exercise routine can significantly protect your muscle tissue while accelerating fat loss.

According to the EAS presentation, subjects who paired semaglutide with exercise achieved an impressive 45% fat loss, compared to 31% in those using the medication alone. Even more importantly, adding exercise reduced lean mass loss from 11% down to just 8%, proving that lifestyle modifications can preserve physical strength during treatment.

What the Data Suggests About Body Composition

These findings help reassure patients that losing "lean mass" during weight loss is not the same as losing functional muscle. Much of what registers as lean mass loss on a scale actually includes body water, glycogen stores, and organ adaptation. A separate real-world study of 486 patients presented at the European Congress on Obesity (ECO) 2026 confirmed this, showing that:

• Between 80% and 85% of the total weight lost was pure fat mass.
• Relative skeletal muscle mass remained stable throughout the treatment period.
• Overall body composition ratios (the ratio of muscle to fat) improved significantly.

This means that weight care programs are highly effective at targeting fat while leaving skeletal muscle largely intact.

The LEAN-PREP Trial: A Closer Look

To further explore muscle preservation, the Dasman Diabetes Institute has launched the LEAN-PREP clinical trial. According to its ClinicalTrials.gov record (NCT06885736), this six-month trial has enrolled 232 participants to compare different protective strategies. The study splits patients into four distinct treatment groups:

• GLP-1 therapy alone to establish a baseline.
• GLP-1 therapy paired with home-based resistance exercises three times per week.
• GLP-1 therapy combined with high-protein intake (targeting 1.6 grams per kilogram daily).
• GLP-1 therapy combining both resistance exercise and high-protein supplementation.

Published in April 2026, the study protocol aims to establish clinical guidelines for protecting physical function and muscle health from the very start of medical weight care.

What Experts Recommend for Patients

While the final LEAN-PREP results are pending, the early data offers clear, actionable steps for anyone enrolled in semaglutide treatment programs. Clinicians advise incorporating the following strategies into your daily routine:

• Perform strength or resistance training at least two to three times per week.
• Consume 1.2 to 1.6 grams of protein per kilogram of body weight every day.
• Start your exercise program early, ideally during the first few weeks of taking the medication.
• Track your progress using body composition scans (like DXA) rather than just the bathroom scale.

A recent analysis in the BMJ points out that adding exercise to your GLP-1 routine also provides extra benefits for your heart, including better blood pressure and cholesterol levels.

The Bigger Picture

Preserving muscle mass is vital for maintaining a healthy metabolism and long-term physical independence. By combining advanced medical treatments with structured exercise and proper nutrition, you can maximize fat loss while keeping your body strong. If you want to start a comprehensive, medically supervised weight care program, you can check if they qualify today.

This article is for informational purposes only and is not medical advice. Consult your healthcare provider before starting any weight loss medication or treatment.